Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1301 - 1325 of 1417 in total
Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.
Investigational
Investigational
Investigational
Experimental
Vet approved
AZD1981 has been used in trials studying the treatment and basic science of Asthma, Postmenopausal, Pharmakokinetic, Asthma Patients, and Drug Interaction, among others.
Investigational
BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.
Investigational
Vidupiprant has been used in trials studying the treatment and basic science of Asthma.
Investigational
SAR405838 has been used in trials studying the treatment of Neoplasm Malignant.
Investigational
CEP-37440 has been used in trials studying the treatment of Solid Tumors.
Investigational
Experimental
Investigational
An anthranilic acid derivative with analgesic properties used for the relief of all types of pain. Glafenine is withdrawn from the American market.
Withdrawn
Displaying drugs 1301 - 1325 of 1417 in total